Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2019 Feb;17(3):510-517.e3.
doi: 10.1016/j.cgh.2018.06.027. Epub 2018 Jun 20.

Assessment of Liver Fibrosis With Elastography Point Quantification vs Other Noninvasive Methods

Affiliations
Comparative Study

Assessment of Liver Fibrosis With Elastography Point Quantification vs Other Noninvasive Methods

Fabio Conti et al. Clin Gastroenterol Hepatol. 2019 Feb.

Abstract

Background & aims: Elastography point quantification (ElastPQ) is a non-invasive method for assessing liver fibrosis based on liver stiffness. We evaluated the accuracy of ElastPQ for the staging of liver fibrosis in patients with chronic liver disease (CLD) compared with aspartate transaminase to platelet ratio index, fibrosis-4 index, and transient elastography (TE), using liver biopsy as reference standard.

Methods: We performed a retrospective study of 406 patients with CLD of any etiology who underwent liver biopsy analysis from September 2012 through June 2017 at a clinic in Bologna, Italy. We obtained liver stiffness measurements, made by ElastPQ and TE, for 361 patients. Liver fibrosis stage was assessed by the METAVIR scoring system. Areas under the receiver operating characteristic curve (AUROC) were used to assess the diagnostic performance of ElastPQ.

Results: ElastPQ values correlated with histologic detection of fibrosis (r = 0.718; P < .001). The AUROC values were 0.856 for detection of significant fibrosis (F≥2), 0.951 for advanced fibrosis (F≥3), and 0.965 for cirrhosis. The best cut-off values identified for classifying patients with F≥2, F≥3, or cirrhosis were 6.0 kPa, 6.2 kPa, and 9.5 kPa, respectively: these were lower than those for TE. Comparison of ElastPQ with TE data resulted in superimposable diagnostic accuracy of both methods for each stage of liver fibrosis. Both elastography techniques performed better than aspartate transaminase to platelet ratio index or fibrosis-4 index scores (P < .05 for all AUROC comparisons).

Conclusions: ElastPQ has good to excellent performance for the non-invasive staging of liver fibrosis in patients with CLD. ElastPQ identified patients with fibrosis or cirrhosis with levels of accuracy that were not inferior to those of TE, and outperformed serum fibrosis indexes in identifying each stage of liver fibrosis.

Keywords: Fibrosis; Liver Biopsy; Liver Stiffness; Noninvasive Assessment.

PubMed Disclaimer

Comment in

  • Assessment of Liver Fibrosis With Elastography Point Quantification Versus Transient Elastography.
    Warringa N, Dam-Vervloet LJ, Boomsma MF. Warringa N, et al. Clin Gastroenterol Hepatol. 2021 Mar;19(3):618-619. doi: 10.1016/j.cgh.2020.03.027. Epub 2020 Mar 18. Clin Gastroenterol Hepatol. 2021. PMID: 32200085 No abstract available.
  • Reply.
    Conti F, Serra C, Andreone P. Conti F, et al. Clin Gastroenterol Hepatol. 2021 Mar;19(3):619. doi: 10.1016/j.cgh.2020.04.072. Epub 2020 Nov 26. Clin Gastroenterol Hepatol. 2021. PMID: 33248100 No abstract available.

Substances